Concepts in epidemiology: the cohort effect
Author: Terence M Mills
Published online: 19 March 2012
Incidence rates of cancer vary over time;1 this is called a “period effect”. Incidence rates of cancer also tend to increase with age;1 this is called an “age effect”. Another time variable that is associated with the incidence of cancer is year of birth of the patient — the “cohort effect”. Many authors have used real data to emphasise the importance of cohort effects for assessing trends in incidence.2,3 Here, I present a simple, hypothetical example to illustrate the cohort effect.
Consider the data shown in the Box. In this hypothetical population, the age groups are 0–29, 30–59 and 60–89 years and everyone dies on their 90th birthday. The Box contains data for three years (1940, 1970 and 2000). For each year and age group, n denotes the size of the population, P denotes the probability of being diagnosed with cancer in the year, and EI denotes the expected incidence (the expected number of new cases of cancer), which is calculated with the formula:
In 1940, in the 0–29-year age group, there were 600 people, the probability of being diagnosed with cancer was 0.01, and the EI was thus 600 × 0.01 = 6. In the whole population, 41 of 1000 people are expected to be diagnosed with cancer.
In this scenario, a wonder drug that prevents cancer was discovered in 1941. However, it must be administered in utero, so only people born since 1941 can benefit.
In 1970, assume there were 100 people aged 0–29 years. In this group, the probability of being diagnosed with cancer was 0, because they were born since 1941, and the EI was 0. The 600 people, who were aged 0–29 years in 1940, were aged 30–59 years in 1970; the probability of being diagnosed with cancer in that age group was 0.05, as in 1940; so the EI was 30. In the whole population, 90 of 1000 people are expected to be diagnosed with cancer in 1970.
In 2000, only those aged 60–89 years were born before 1941. Overall, 120 of 1000 people are expected to be diagnosed with cancer.
Thus, in 1940 there would be 41 new cases in a population of 1000, in 1970 there would be 90 new cases in a population of 1000, and in 2000 there would be 120 new cases in a population of 1000. This trend suggests that things will be worse in 2030.
In fact, the disease will disappear in 2030.
A hypothetical population that illustrates the cohort effect
Competing interests
References
- Australian Institute of Health and Welfare. Cancer in Australia 2010: an overview. Canberra: AIHW, 2010. (AIHW Cat. No. 56; Cancer Series No. 60.) 0_CHDJEJHD
- Gardner MJ, Osmond C. Interpretation of disease time trends: is cancer on the increase? A simple cohort technique and its relationship to more advanced models. J Epidemiol Community Health 1983; 37: 274-278. 0_i1143011
- Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 1991; 12: 425-457. 0_i1143013
Challenges and Opportunities for Strong and Dynamic Foundations in the Australian Cancer Plan
Ashley M. Hopkins, Andrew Rowland, Natansh D. Modi, Ceara Rickard, Mark Haseloff, Norma B. Bulamu, Imogen Ramsey, Niranjan Bidargaddi, Ganessan Kichenadasse, Michael J. Sorich, Kalinda E. Griffiths, Aideen McInerney-Leo, David M. Roder, Raymond J. Chan
Opportunities and Challenges to Achieving the Australian Cancer Plan Goal of World Class Health Systems for Optimal Cancer Care
Carolyn Ee, Ria Joseph, Elise Button, Stacey George, Makala Castelli, David Currow, Prue Cormie, Olivia Farrer, Michael Jefford, Nicolas H. Hart, Chad Y. Han, Deidre D. Morgan, Michael P. Osborn, Candice Oster, Joel Rhee, Anna Ugalde, Eric Yeung, Catherine Paterson
Maximising Cancer Prevention and Early Detection in the Australian Cancer Plan: Where Are We Now and What Should Come Next?
Erin L. Symonds, Billie Bonevski, Richard Edwards, Nathan J. Harrison, Sana Ishaque, Nicole M. Rankin, Sibel Saya, Renee J. Smith, Carolyn Ee
An Australian Narrative Review of Adoptive Cellular Therapies in Malignancy: Expanding Indications, Referral Pathways and Safety Beyond Specialist Centres
Sarah Childs, David Ma, Anthony Rodrigues, Jennifer Massey, Rasha Cosman, Venessa Chin, Laila Girgis, James Lynam, Peter Lau, Barbara Withers, Anthony M. Joshua, Ben Tran, Jayesh Desai, Simon J. Harrison, John Moore, Jia Liu
Peritoneal Tuberculosis and Chronic Myeloid Leukaemia: A Case of Hickam's Dictum
Zayn Al-Timimi, Gem Chew, Martin Browne, Christiaan Mostert
From Ambition to Action: Closing Policy, Equity and Implementation Gaps in the Australian Cancer Plan's ‘Enhanced Consumer Experience’
Carla Thamm, Elise Button, Oluwaseyifunmi A. Agbejule, Reegan Knowles, Karen van Gorp, Mark B. Pinkham, Meinir Krishnasamy, Alexandra L. McCarthy, Raymond J. Chan